Kelly H. Tyler MD, FACOG, FAAD
Assistant Professor, Division of Dermatology, Department of Internal Medicine, Department of Obstetrics and Gynecology, Ohio State University Wexner Medical Center, Columbus, OhioKelly Tyler, MD is a Board-Certified Dermatologist and Board-Certified Obstetrician/Gynecologist at the Ohio State University Wexner Medical Center specializing in Medical Dermatology with a focus on both vulvar disease and skin disease in pregnancy. She is also the Director of the Allergic Contact Dermatitis Program and serves as the Assistant Residency Program Director. Dr. Tyler is the editor of the upcoming textbook “Cutaneous Disorders of Pregnancy” and is the Principal Investigator on multiple clinical research trials. She has lectured on both Pregnancy and Medication Safety and Vulvar Dermatoses at the AAD national meeting and has been active as a member of several national committees through the AAD, WDS, and ASDS.
Disclosures
Dr. Tyler is Principal Investigator for Janssen, Celgene, and Lilly.
Recent Contributions to PracticeUpdate:
- Association of Hidradenitis Suppurativa With Adverse Outcomes in Pregnant Patients and Their Offspring
- Incidence and Management of Acne After Long-Acting Reversible Contraception Use in Adolescents and Young Adults
- Impact of Hormonal Contraception Type on Hidradenitis Suppurativa Disease Control
- Margin Positivity Rates After Standard Excision of Vulvar Melanomas
- Relationship Between Adverse Pregnancy Outcomes and Serum Anti-BP180 IgG Antibody Levels in Patients With Pemphigoid Gestationis
- Use of Laser Therapy for Treating Vulvar Skin Conditions
- State Medicaid Coverage of HPV Vaccination in Adults and Implications for Dermatologists
- Epidemiology and Clinicopathology in Genital Dermatoses
- Maternal and Neonatal Outcomes in Pregnant Women With Psoriasis and Psoriatic Arthritis
- Pregnancy Outcomes in Women With Moderate to Severe Psoriasis